The ultimate goal for the use of GRNOPC1 is restore spinal cord function by injecting hESC-derived oligodendrocyte progenitor cells directly into the patient’s injured spinal cord.
FDA OK's Embryonic Stem Cell Therapy
Here's some good news:
Related articles
- First Human Stem Cell Clinical Trial- Why It Matters
- Why Is Squid Skin So Complicated, Anyway?
- Embryonic Stem Cell Treatment Restores Walking Ability In Rats
- Garth Sundem on CBS News' "The Early Show" tomorrow morning
- Solid-State Laser Weapons- Because America Is Not Far Enough Ahead Of The Rest Of The World





Comments